Lv1
30 积分 2021-09-08 加入
The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
2个月前
已完结
Renal recovery and clinical outcomes with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma with severe renal impairment
2个月前
已完结
Efficacy and safety of zanubrutinib combined with age-adapted bendamustine and rituximab followed by zanubrutinib maintenance therapy in elderly patients with mantle cell lymphoma: a retrospective analysis
2个月前
已完结
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
3个月前
已完结
Trium study: Exploring MRD-guided triplet therapy with sonrotoclax, zanubrutinib, and CD20mab in Untreated Mantle Cell Lymphoma: A prospective, multicenter, Phase II Study
7个月前
已关闭
53P Distinct cellular and molecular patterns in pre-treatment peripheral blood are associated with CAR-T outcomes in diffuse large B-cell lymphoma
9个月前
已完结
The Treatment of Marginal Zone Lymphoma
1年前
已完结
Subclasses Selection in Therapeutic Antibody Development
1年前
已完结
皖公网安备34019202002308
